Drug & supplement interaction

Beta-cryptoxanthin + Ramucirumab

Ramucirumab brand name: Cyramza.

No Known Interaction
The bottom line No known interaction

We found no known interaction between Beta-cryptoxanthin and Ramucirumab in our sources. Absence of a documented interaction is not the same as proven safety, and does not guarantee one does not exist. Do not start, stop, or change a medication or supplement based on this page; confirm with your pharmacist or doctor first.

Know someone taking this? Share
Interaction report

Beta-cryptoxanthin and Ramucirumab

We checked these two against our interaction database. Here is what we found.

No Known Interaction Found

We did not find a documented interaction between Ramucirumab and Beta-cryptoxanthin in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

Worth understanding: our licensed dataset holds no drug-interaction record for Beta-cryptoxanthin at all — not against Ramucirumab, and not against any other medication we track. This verdict therefore rests on the absence of any recorded data, not on research that looked at this combination and found nothing. We cannot rule an interaction out.

If you decide to take both, the practical routine is simple: add one new thing at a time and note the date you started it. If the combination is going to disagree with you, it usually shows in the first days to a couple of weeks — and a start date turns “I’ve been feeling off” into something a pharmacist can actually work with. Do not stop a prescribed medicine on your own.

Always talk with your pharmacist or doctor before making changes to your medications or supplements, particularly if you take several medications or have an ongoing health condition.

Beta-cryptoxanthin safety at a glance

Beta-cryptoxanthin overall Use caution Considered safe in normal food amounts, but the safety of high-dose supplements is not well studied.
Pregnancy Likely Safe When used orally and appropriately in amounts found in foods. There is insufficient reliable information available about the safety of supplemental beta-cryptox... Read the full pregnancy detail
Breastfeeding Likely Safe When used orally and appropriately in amounts found in foods. There is insufficient reliable information available about the safety of supplemental beta-cryptox... Read the full breastfeeding detail

Pregnancy & breastfeeding ratings are from Natural Medicines (Therapeutic Research Center) — the full detail is in the Special populations card below. Safety guidance is general; always confirm with your pharmacist or doctor for your situation.

Still wondering about combining Ramucirumab and Beta-cryptoxanthin? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
What to actually watch for

What Ramucirumab’s Own FDA Label Lists

This is not an interaction — none of it involves Beta-cryptoxanthin. These are the most notable effects listed in the ADVERSE REACTIONS section of Ramucirumab’s own FDA label, for the medication by itself. Knowing the drug’s own list makes it easier to work out the likely cause if something new turns up while you take both. 10 of them are worth acting on rather than waiting out — marked below.

  • A bowel blockage Worth acting on
  • Low sodium Worth acting on
  • A low white blood cell count Worth acting on mentioned in 8.5% of FDA reports for Ramucirumab
  • A low platelet count Worth acting on
  • Kidney problems Worth acting on
  • Anemia Worth acting on
  • Raised blood pressure Worth acting on
  • Liver problems Worth acting on
  • Bleeding or bruising Worth acting on
  • A higher chance of infection Worth acting on

Showing the 10 most notable of 19 label-listed effects — ranked by how unusual each one is across medicines generally, with serious effects weighted up.

From the ADVERSE REACTIONS section of the FDA label for Ramucirumab. Read the label on DailyMed › Where a percentage is shown, it is the share of 6,109 voluntary FDA FAERS reports for Ramucirumab that mention that effect — a reporting proportion, not an incidence rate and not evidence the drug caused it. Beta-cryptoxanthin’s licensed record lists no adverse effects our clinical vocabulary could match, so there is no Beta-cryptoxanthin side to compare — that is a limit of the record, not a statement that Beta-cryptoxanthin has no side effects.

Special populations

Beta-cryptoxanthin in Pregnancy & Breastfeeding

Pregnancy And Lactation Likely Safe

When used orally and appropriately in amounts found in foods. There is insufficient reliable information available about the safety of supplemental beta-cryptoxanthin; avoid use.

DISCLAIMER: This tool is intended for informational purposes only, and should not be interpreted as specific medical advice. Patients should consult with a qualified healthcare provider before making decisions about therapies and/or health conditions.© 2026 Therapeutic Research Center

Overlapping uses

What Ramucirumab Is Prescribed For, and What Beta-cryptoxanthin Has Been Studied For

These two come up together because they touch the same health topic — not because they do the same job. Ramucirumab is a prescription medicine with approved uses on its FDA label. Beta-cryptoxanthin is a supplement: what follows is what researchers have looked at it for, and how strong that evidence is.

Ramucirumab is prescribed for: Cyramza (ramucirumab) injection is used to treat several types of advanced or metastatic cancer in adults. It is used for advanced or metastatic gastric (stomach) cancer or gastro-esophageal junction cancer that has progressed after prior chemotherapy — either alone or combined with paclitaxel. It is also used for metastatic non-small cell lung cancer, either with erlotinib as a first-line treatment for tumors with certain EGFR mutations, or with docetaxel after platinum-based chemotherapy has stopped working. Additionally, Cyramza is used with FOLFIRI chemotherapy for metastatic colorectal cancer that has progressed after certain prior treatments, and as a single agent for hepatocellular carcinoma (a type of liver cancer) in patients who have elevated alpha-fetoprotein levels and have already received sorafenib.

Beta-cryptoxanthin has been studied for:

  • Lung cancer studied, not established Beta-cryptoxanthin has been studied for this. Natural Medicines rates the evidence: Insufficient Reliable Evidence To Rate Read what the research shows

    Beta-cryptoxanthin for lung cancer

    It is unclear if dietary beta-cryptoxanthin intake can reduce the risk of lung cancer.

Effectiveness ratings and the research summaries above are the verbatim record from the Natural Medicines database, which grades evidence from “Effective” down to “Insufficient Reliable Evidence To Rate”. A rating below the top of that scale means researchers have looked at it — not that it works, and never that it can stand in for a prescribed medicine. Do not stop or replace Ramucirumab on your own; if you are taking Beta-cryptoxanthin for the same health topic, tell your prescriber, especially if the medicine is being adjusted to a target.

How much people look this up

Where Beta-cryptoxanthin and Ramucirumab Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Beta-cryptoxanthin
Steady interest

#1,269 of 1,452 supplements looked up here in the last 7 days

29 days ago today
Medication Ramucirumab
Steady interest

#2,745 of 2,830 medications looked up here in the last 7 days

29 days ago today

Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.

Where does our data come from?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions. Beta-cryptoxanthin is not yet covered by that licensed database, so its write-up cites publicly available medical sources directly (see the references below).
  • Citation library: 103,510 references behind our interaction content, 65,311 of them resolved to verified PubMed/DOI sources. See every Beta-cryptoxanthin reference on this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified September 20, 2026. The Beta-cryptoxanthin and Ramucirumab records this page draws on were last updated July 11, 2026.
  • What “no known interaction” means: no documented interaction in the sources above — not a guarantee of safety. Supplements are studied far less than prescription drugs, so we say exactly what the evidence supports, and nothing more.
Data structure & sourcing designed and verified by .
Supplement

About Beta-cryptoxanthin

What is Beta-cryptoxanthin?

  • Antioxidant support
  • Eye health
  • Bone health
  • Vitamin A source
  • General wellness

Beta-cryptoxanthin is a natural orange-red plant pigment (a carotenoid) found in fruits like oranges, tangerines, and papaya, and it can be turned into vitamin A in the body. Diets rich in beta-cryptoxanthin are linked in some studies to better bone and lung health, but the evidence for supplements is limited. For most people, getting it from colorful fruits and vegetables is the safest and best-studied approach.

Naturally found in fruits and vegetables; also made as a supplement · Capsules, softgels, and multivitamin/carotenoid blends; naturally present in whole foods

An interaction check asks whether these two react with each other — it does not ask whether Beta-cryptoxanthin is a good idea for someone in your situation. Here is what our Beta-cryptoxanthin record says about it on its own.

Beta-cryptoxanthin: dosing

There is no established standard supplement dose for beta-cryptoxanthin. Most research reflects amounts obtained through a normal diet rich in fruits and vegetables rather than from pills.If you choose to take a supplement, follow the directions on the product label and do not exceed the recommended amount.

From our Beta-cryptoxanthin monograph — the full record covers uses, side effects and every documented interaction.

Read the full Beta-cryptoxanthin monograph & all interactions
Medication

About Ramucirumab Injection

What Is Ramucirumab Injection Used For?

Brand name: Cyramza

Cyramza (ramucirumab) injection is used to treat several types of advanced or metastatic cancer in adults. It is used for advanced or metastatic gastric (stomach) cancer or gastro-esophageal junction cancer that has progressed after prior chemotherapy — either alone or combined with paclitaxel. It is also used for metastatic non-small cell lung cancer, either with erlotinib as a first-line treatment for tumors with certain EGFR mutations, or with docetaxel after platinum-based chemotherapy has stopped working.

Additionally, Cyramza is used with FOLFIRI chemotherapy for metastatic colorectal cancer that has progressed after certain prior treatments, and as a single agent for hepatocellular carcinoma (a type of liver cancer) in patients who have elevated alpha-fetoprotein levels and have already received sorafenib.

Most-Reported Side Effects for Ramucirumab

From FAERS, the FDA’s public side-effect reporting system (0 reports, all brands). Reports are voluntary and are not proof the drug caused the effect.

Malignant neoplasm progression 810 reports
Interstitial lung disease 299 reports
Neutropenia 263 reports
Febrile neutropenia 262 reports
Decreased appetite 231 reports
See full Ramucirumab Injection drug information
Keep checking

Other Drugs & Beta-cryptoxanthin

Browse every other medication we’ve checked against Beta-cryptoxanthin — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
0Moderate
0Minor
2,829No known interaction
No interaction 2,829 drugs checked — show the list
Evidence & sources

Beta-cryptoxanthin References

The 2 sources that drive our Beta-cryptoxanthin monograph — publicly available pages from reputable medical and government organizations. Every link was verified to work before publishing. Beta-cryptoxanthin is not covered by the licensed Natural Medicines interaction database, so its page cites these public sources directly.

  1. Vitamin A and Carotenoids - Health Professional Fact Sheet — NIH Office of Dietary Supplements Source
  2. Vitamin A — MedlinePlus Source

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is written and reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.

Pharmacist Counseling Corner

Taking Beta-cryptoxanthin and Ramucirumab Together: Common Questions

Is it safe to take Beta-cryptoxanthin with Ramucirumab?
We do not list a known interaction between Beta-cryptoxanthin and Ramucirumab. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.
Are Beta-cryptoxanthin and Ramucirumab used for the same thing?
They overlap in purpose, which usually means the real question is whether you need both rather than whether they are safe together. This page lists the shared uses and how strong the evidence is for Beta-cryptoxanthin in each. That is a conversation for your prescriber, especially if Ramucirumab is being adjusted to a target.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Still Have a Question About Ramucirumab and Beta-cryptoxanthin?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.